[Prescription of betablockers in chronic cardiac failure: results of a national enquiry of cardiologists].
Despite recommendations from various learned establishments, there are strong reservations regarding betablockers, which have been contra-indicated in chronic cardiac failure for a long time. Several published enquiries have found a low prescription rate for betablockers. We performed an enquiry into the apparent modes of betablocker prescription in chronic cardiac failure. Questionnaires were sent to all the cardiologists in France, and 1622 were analysed. The dosage used, reasons for non-prescription, modes of repeat prescription, and the influence of the response to treatment were analysed. This enquiry shows that although the advantage of betablockers is acknowledged, there is still a block to their use.
Cohen Solal
A
A
Cardiologie, hôpital Beaujon, Clichy.
Johnson
N
N
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D004305:Dose-Response Relationship, Drug; D005260:Female; D005602:France; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010818:Practice Patterns, Physicians'; D011795:Surveys and Questionnaires
D000319:Adrenergic beta-Antagonists